BioCentury
ARTICLE | Company News

Amgen, ImmunoGen deal

November 7, 2011 8:00 AM UTC

ImmunoGen received a $1 million milestone payment from Amgen under a 2000 deal granting Abgenix Inc. rights to ImmunoGen's maytansinoid Targeted Antibody Payload (TAP) technology. Amgen acquired Abge...